PhytaGenics Inc.
This article was originally published in Start Up
Executive Summary
PhytaGenics is using transgenic technology to produce high-value pharmaceutical proteins and bulk enzymes in the leaves of potato plants as well as other species, under greenhouse conditions.
You may also be interested in...
Protein Production Start-Ups
Should a disruptive protein production technology emerge, the current interest in developing large-molecule therapeutics assures there would be many takers.
Understanding How To Develop BTK Inhibitors In MS Is Evolving
Having a reversible BTK inhibitor in the multiple sclerosis armamentarium could be the best way to favorably impact the treatment landscape.